1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cardiac Catheterization
1.2.3 Electrocardiogram (ECG)
1.2.4 Chest X-Ray
1.2.5 Stress Test
1.2.6 Others
1.3 Market by Application
1.3.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Valvular Heart Disease Treatment Market Perspective (2017-2028)
2.2 Valvular Heart Disease Treatment Growth Trends by Region
2.2.1 Valvular Heart Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Valvular Heart Disease Treatment Historic Market Size by Region (2017-2022)
2.2.3 Valvular Heart Disease Treatment Forecasted Market Size by Region (2023-2028)
2.3 Valvular Heart Disease Treatment Market Dynamics
2.3.1 Valvular Heart Disease Treatment Industry Trends
2.3.2 Valvular Heart Disease Treatment Market Drivers
2.3.3 Valvular Heart Disease Treatment Market Challenges
2.3.4 Valvular Heart Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Valvular Heart Disease Treatment Players by Revenue
3.1.1 Global Top Valvular Heart Disease Treatment Players by Revenue (2017-2022)
3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Valvular Heart Disease Treatment Revenue
3.4 Global Valvular Heart Disease Treatment Market Concentration Ratio
3.4.1 Global Valvular Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Valvular Heart Disease Treatment Revenue in 2021
3.5 Valvular Heart Disease Treatment Key Players Head office and Area Served
3.6 Key Players Valvular Heart Disease Treatment Product Solution and Service
3.7 Date of Enter into Valvular Heart Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Valvular Heart Disease Treatment Breakdown Data by Type
4.1 Global Valvular Heart Disease Treatment Historic Market Size by Type (2017-2022)
4.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2023-2028)
5 Valvular Heart Disease Treatment Breakdown Data by Application
5.1 Global Valvular Heart Disease Treatment Historic Market Size by Application (2017-2022)
5.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Valvular Heart Disease Treatment Market Size (2017-2028)
6.2 North America Valvular Heart Disease Treatment Market Size by Type
6.2.1 North America Valvular Heart Disease Treatment Market Size by Type (2017-2022)
6.2.2 North America Valvular Heart Disease Treatment Market Size by Type (2023-2028)
6.2.3 North America Valvular Heart Disease Treatment Market Share by Type (2017-2028)
6.3 North America Valvular Heart Disease Treatment Market Size by Application
6.3.1 North America Valvular Heart Disease Treatment Market Size by Application (2017-2022)
6.3.2 North America Valvular Heart Disease Treatment Market Size by Application (2023-2028)
6.3.3 North America Valvular Heart Disease Treatment Market Share by Application (2017-2028)
6.4 North America Valvular Heart Disease Treatment Market Size by Country
6.4.1 North America Valvular Heart Disease Treatment Market Size by Country (2017-2022)
6.4.2 North America Valvular Heart Disease Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Valvular Heart Disease Treatment Market Size (2017-2028)
7.2 Europe Valvular Heart Disease Treatment Market Size by Type
7.2.1 Europe Valvular Heart Disease Treatment Market Size by Type (2017-2022)
7.2.2 Europe Valvular Heart Disease Treatment Market Size by Type (2023-2028)
7.2.3 Europe Valvular Heart Disease Treatment Market Share by Type (2017-2028)
7.3 Europe Valvular Heart Disease Treatment Market Size by Application
7.3.1 Europe Valvular Heart Disease Treatment Market Size by Application (2017-2022)
7.3.2 Europe Valvular Heart Disease Treatment Market Size by Application (2023-2028)
7.3.3 Europe Valvular Heart Disease Treatment Market Share by Application (2017-2028)
7.4 Europe Valvular Heart Disease Treatment Market Size by Country
7.4.1 Europe Valvular Heart Disease Treatment Market Size by Country (2017-2022)
7.4.2 Europe Valvular Heart Disease Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Valvular Heart Disease Treatment Market Size (2017-2028)
8.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Valvular Heart Disease Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Valvular Heart Disease Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Valvular Heart Disease Treatment Market Size (2017-2028)
9.2 Latin America Valvular Heart Disease Treatment Market Size by Type
9.2.1 Latin America Valvular Heart Disease Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Valvular Heart Disease Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Valvular Heart Disease Treatment Market Share by Type (2017-2028)
9.3 Latin America Valvular Heart Disease Treatment Market Size by Application
9.3.1 Latin America Valvular Heart Disease Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Valvular Heart Disease Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Valvular Heart Disease Treatment Market Share by Application (2017-2028)
9.4 Latin America Valvular Heart Disease Treatment Market Size by Country
9.4.1 Latin America Valvular Heart Disease Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Valvular Heart Disease Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Valvular Heart Disease Treatment Market Size (2017-2028)
10.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Valvular Heart Disease Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Valvular Heart Disease Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Details
11.2.2 B. Braun Melsungen AG Business Overview
11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Introduction
11.2.4 B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.2.5 B. Braun Melsungen AG Recent Developments
11.3 Boston Scientific Corp.
11.3.1 Boston Scientific Corp. Company Details
11.3.2 Boston Scientific Corp. Business Overview
11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Introduction
11.3.4 Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.3.5 Boston Scientific Corp. Recent Developments
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Valvular Heart Disease Treatment Introduction
11.4.4 Medtronic Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.4.5 Medtronic Recent Developments
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Details
11.5.2 CryoLife Inc. Business Overview
11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Introduction
11.5.4 CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.5.5 CryoLife Inc. Recent Developments
11.6 Edwards Lifesciences Corporation
11.6.1 Edwards Lifesciences Corporation Company Details
11.6.2 Edwards Lifesciences Corporation Business Overview
11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Introduction
11.6.4 Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.6.5 Edwards Lifesciences Corporation Recent Developments
11.7 LivaNova PLC
11.7.1 LivaNova PLC Company Details
11.7.2 LivaNova PLC Business Overview
11.7.3 LivaNova PLC Valvular Heart Disease Treatment Introduction
11.7.4 LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.7.5 LivaNova PLC Recent Developments
11.8 Neovasc Inc.
11.8.1 Neovasc Inc. Company Details
11.8.2 Neovasc Inc. Business Overview
11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Introduction
11.8.4 Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.8.5 Neovasc Inc. Recent Developments
11.9 Micro Interventional Devices
11.9.1 Micro Interventional Devices Company Details
11.9.2 Micro Interventional Devices Business Overview
11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Introduction
11.9.4 Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.9.5 Micro Interventional Devices Recent Developments
11.10 Symetis SA
11.10.1 Symetis SA Company Details
11.10.2 Symetis SA Business Overview
11.10.3 Symetis SA Valvular Heart Disease Treatment Introduction
11.10.4 Symetis SA Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.10.5 Symetis SA Recent Developments
11.11 Jenavalve Technology
11.11.1 Jenavalve Technology Company Details
11.11.2 Jenavalve Technology Business Overview
11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Introduction
11.11.4 Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.11.5 Jenavalve Technology Recent Developments
11.12 TTK Healthcare Limited
11.12.1 TTK Healthcare Limited Company Details
11.12.2 TTK Healthcare Limited Business Overview
11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Introduction
11.12.4 TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.12.5 TTK Healthcare Limited Recent Developments
11.13 Colibri Heart Valve
11.13.1 Colibri Heart Valve Company Details
11.13.2 Colibri Heart Valve Business Overview
11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Introduction
11.13.4 Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.13.5 Colibri Heart Valve Recent Developments
11.14 Lepu Medical Technology Co.
11.14.1 Lepu Medical Technology Co. Company Details
11.14.2 Lepu Medical Technology Co. Business Overview
11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Introduction
11.14.4 Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.14.5 Lepu Medical Technology Co. Recent Developments
11.15 Braile Biomédica
11.15.1 Braile Biomédica Company Details
11.15.2 Braile Biomédica Business Overview
11.15.3 Braile Biomédica Valvular Heart Disease Treatment Introduction
11.15.4 Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2017-2022)
11.15.5 Braile Biomédica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cardiac Catheterization
Table 3. Key Players of Electrocardiogram (ECG)
Table 4. Key Players of Chest X-Ray
Table 5. Key Players of Stress Test
Table 6. Key Players of Others
Table 7. Global Valvular Heart Disease Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Valvular Heart Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Valvular Heart Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Valvular Heart Disease Treatment Market Share by Region (2017-2022)
Table 11. Global Valvular Heart Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Valvular Heart Disease Treatment Market Share by Region (2023-2028)
Table 13. Valvular Heart Disease Treatment Market Trends
Table 14. Valvular Heart Disease Treatment Market Drivers
Table 15. Valvular Heart Disease Treatment Market Challenges
Table 16. Valvular Heart Disease Treatment Market Restraints
Table 17. Global Valvular Heart Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Valvular Heart Disease Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Valvular Heart Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valvular Heart Disease Treatment as of 2021)
Table 20. Ranking of Global Top Valvular Heart Disease Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Valvular Heart Disease Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Valvular Heart Disease Treatment Product Solution and Service
Table 24. Date of Enter into Valvular Heart Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Valvular Heart Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Valvular Heart Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Valvular Heart Disease Treatment Revenue Share by Application (2017-2022)
Table 32. Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Valvular Heart Disease Treatment Revenue Share by Application (2023-2028)
Table 34. North America Valvular Heart Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Valvular Heart Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Valvular Heart Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Valvular Heart Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Valvular Heart Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Valvular Heart Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Valvular Heart Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Valvular Heart Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Valvular Heart Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Valvular Heart Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Valvular Heart Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Valvular Heart Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Valvular Heart Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Valvular Heart Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Valvular Heart Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Valvular Heart Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Valvular Heart Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Valvular Heart Disease Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Valvular Heart Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Valvular Heart Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Valvular Heart Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Valvular Heart Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Valvular Heart Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Valvular Heart Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Valvular Heart Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Valvular Heart Disease Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Valvular Heart Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Valvular Heart Disease Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Valvular Heart Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Valvular Heart Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Valvular Heart Disease Treatment Product
Table 67. Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 68. Abbott Laboratories Recent Developments
Table 69. B. Braun Melsungen AG Company Details
Table 70. B. Braun Melsungen AG Business Overview
Table 71. B. Braun Melsungen AG Valvular Heart Disease Treatment Product
Table 72. B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 73. B. Braun Melsungen AG Recent Developments
Table 74. Boston Scientific Corp. Company Details
Table 75. Boston Scientific Corp. Business Overview
Table 76. Boston Scientific Corp. Valvular Heart Disease Treatment Product
Table 77. Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 78. Boston Scientific Corp. Recent Developments
Table 79. Medtronic Company Details
Table 80. Medtronic Business Overview
Table 81. Medtronic Valvular Heart Disease Treatment Product
Table 82. Medtronic Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 83. Medtronic Recent Developments
Table 84. CryoLife Inc. Company Details
Table 85. CryoLife Inc. Business Overview
Table 86. CryoLife Inc. Valvular Heart Disease Treatment Product
Table 87. CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 88. CryoLife Inc. Recent Developments
Table 89. Edwards Lifesciences Corporation Company Details
Table 90. Edwards Lifesciences Corporation Business Overview
Table 91. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product
Table 92. Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 93. Edwards Lifesciences Corporation Recent Developments
Table 94. LivaNova PLC Company Details
Table 95. LivaNova PLC Business Overview
Table 96. LivaNova PLC Valvular Heart Disease Treatment Product
Table 97. LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 98. LivaNova PLC Recent Developments
Table 99. Neovasc Inc. Company Details
Table 100. Neovasc Inc. Business Overview
Table 101. Neovasc Inc. Valvular Heart Disease Treatment Product
Table 102. Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 103. Neovasc Inc. Recent Developments
Table 104. Micro Interventional Devices Company Details
Table 105. Micro Interventional Devices Business Overview
Table 106. Micro Interventional Devices Valvular Heart Disease Treatment Product
Table 107. Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 108. Micro Interventional Devices Recent Developments
Table 109. Symetis SA Company Details
Table 110. Symetis SA Business Overview
Table 111. Symetis SA Valvular Heart Disease Treatment Product
Table 112. Symetis SA Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 113. Symetis SA Recent Developments
Table 114. Jenavalve Technology Company Details
Table 115. Jenavalve Technology Business Overview
Table 116. Jenavalve Technology Valvular Heart Disease Treatment Product
Table 117. Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 118. Jenavalve Technology Recent Developments
Table 119. TTK Healthcare Limited Company Details
Table 120. TTK Healthcare Limited Business Overview
Table 121. TTK Healthcare Limited Valvular Heart Disease Treatment Product
Table 122. TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 123. TTK Healthcare Limited Recent Developments
Table 124. Colibri Heart Valve Company Details
Table 125. Colibri Heart Valve Business Overview
Table 126. Colibri Heart Valve Valvular Heart Disease Treatment Product
Table 127. Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 128. Colibri Heart Valve Recent Developments
Table 129. Lepu Medical Technology Co. Company Details
Table 130. Lepu Medical Technology Co. Business Overview
Table 131. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product
Table 132. Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 133. Lepu Medical Technology Co. Recent Developments
Table 134. Braile Biomédica Company Details
Table 135. Braile Biomédica Business Overview
Table 136. Braile Biomédica Valvular Heart Disease Treatment Product
Table 137. Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2017-2022) & (US$ Million)
Table 138. Braile Biomédica Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Valvular Heart Disease Treatment Market Share by Type: 2021 VS 2028
Figure 2. Cardiac Catheterization Features
Figure 3. Electrocardiogram (ECG) Features
Figure 4. Chest X-Ray Features
Figure 5. Stress Test Features
Figure 6. Others Features
Figure 7. Global Valvular Heart Disease Treatment Market Share by Application: 2021 VS 2028
Figure 8. Hospital & Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Valvular Heart Disease Treatment Report Years Considered
Figure 12. Global Valvular Heart Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Valvular Heart Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Valvular Heart Disease Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Valvular Heart Disease Treatment Market Share by Players in 2021
Figure 16. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valvular Heart Disease Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2021
Figure 18. North America Valvular Heart Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Valvular Heart Disease Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Valvular Heart Disease Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Valvular Heart Disease Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Valvular Heart Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Valvular Heart Disease Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Valvular Heart Disease Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Valvular Heart Disease Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Valvular Heart Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Valvular Heart Disease Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Valvular Heart Disease Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Valvular Heart Disease Treatment Market Size Share by Region (2017-2028)
Figure 38. China Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Valvular Heart Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Valvular Heart Disease Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Valvular Heart Disease Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Valvular Heart Disease Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Valvular Heart Disease Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Valvular Heart Disease Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Valvular Heart Disease Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Valvular Heart Disease Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Valvular Heart Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 58. B. Braun Melsungen AG Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 59. Boston Scientific Corp. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 60. Medtronic Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 61. CryoLife Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 62. Edwards Lifesciences Corporation Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 63. LivaNova PLC Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 64. Neovasc Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 65. Micro Interventional Devices Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 66. Symetis SA Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 67. Jenavalve Technology Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 68. TTK Healthcare Limited Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 69. Colibri Heart Valve Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 70. Lepu Medical Technology Co. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 71. Braile Biomédica Revenue Growth Rate in Valvular Heart Disease Treatment Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
